(Press-News.org) Semaglutide, an injectable medication taken once a week, offers a nonsurgical way to reduce weight and treat obesity. It could help the more than 70 million adults in the United States who struggle with this chronic condition, says Ildiko Lingvay, M.D., M.P.H., M.S.C.S., professor of internal medicine and population and data sciences at UTSW and lead author of the study, published today in The Lancet.
People with diabetes benefit greatly from weight loss, yet they have a much harder time losing weight compared with those without diabetes, Lingvay says. This study is the first to evaluate the weight loss effect of this medication exclusively in patients with Type 2 diabetes.
This multicenter study was conducted at 149 sites in 12 countries across North America, Europe, South America, the Middle East, South Africa, and Asia from June 2018 to June 2020. It is one of the studies conducted as part of the Semaglutide Treatment Effect for People (STEP) with obesity program. "In the four clinical trials completed so far, people treated with this medication lost on average 10 to 17 percent of their body weight, which is a huge step forward compared with all other medications currently available to treat obesity," says Lingvay. "With this drug, results are getting close to what we see with bariatric surgery, which is 20 to 30 percent weight loss."
Medications from this drug class have been used for more than a decade to treat people with diabetes. Semaglutide is currently approved by the Food and Drug Administration to lower blood sugar in people with diabetes at a dose of 0.5 mg or 1 mg once weekly. The FDA is evaluating use of a higher weekly 2.4 mg dose for chronic weight management.
The STEP 2 study, a randomized, double-blind, double-dummy, placebo-controlled phase 3 clinical trial reported in The Lancet, involved more than 1,200 adults with Type 2 diabetes who were overweight or obese at the time. Over 68 weeks, they injected semaglutide or a placebo once a week. A body mass index (BMI) over 30, or a BMI over 27 along with other comorbidities, was required to participate.
"In this study, more than a quarter of participants lost over 15 percent of their body weight, which is by far the best result we had with any weight loss medicine in patients with diabetes," she says.
Other STEP trials investigating a weekly dose of semaglutide 2.4 mg in obese adults without diabetes reported even greater weight loss of 15 to 16 percent body weight.
The drug works by suppressing appetite centers in the brain to reduce caloric intake, Lingvay adds.
"The medication continually tells the body that you just ate, you're full," she says.
Participants took the subcutaneous injection with a pre-filled pen and tiny needle once a week. They also met with a registered dietitian to help them follow a reduced calorie meal plan.
Average weight loss among participants treated with semaglutide 2.4 mg was 21.4 pounds, compared with 7.7 pounds in the placebo group. About 69 percent of participants treated with semaglutide 2.4 mg lost 5 percent or more of their body weight, which can improve comorbidities such as high blood pressure. Half of those taking semaglutide 2.4 mg achieved weight loss of 10 percent or more, and 25 percent attained weight loss of 15 percent or greater.
For someone with diabetes, losing weight can be especially challenging.
"People with diabetes lose much less weight than their peers without diabetes," Lingvay says. "For people with diabetes, a 10 percent weight loss is a phenomenal accomplishment."
The drug is recommended for lifelong use and is not intended to be stopped once weight loss is achieved, she adds.
"Obesity is a chronic medical condition," Lingvay says. "It is not something you treat like the flu."
INFORMATION:
Side effects, including nausea, vomiting, and diarrhea, were mostly mild, and very few patients stopped taking the medication because of them.
The study was funded by Novo Nordisk, which designed and oversaw the trial. Lingvay has received research funding, advisory/consulting fees and/or other support from Novo Nordisk, and her other disclosures can be found in the manuscript.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty has received six Nobel Prizes, and includes 23 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 13 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.
WEHI researchers have uncovered a process cells use to fight off infection and cancer that could pave the way for precision cancer immunotherapy treatment.
Through gaining a better understanding of how this process works, researchers hope to be able to determine a way of tailoring immunotherapy to better fight cancer.
Led by Dr Dawn Lin and Dr Shalin Naik and published in Nature Cell Biology, the research provides new insight into the way cells adapt to fight infection.
This research lays the foundation for future studies into the body's response to environmental stressors, such as injury, infection or cancer, at a single cell level.
At a glance
WEHI researchers have studied dendritic ...
HPSTAR scientists Dr. Songhao Guo and Dr. Xujie Lü report three orders of magnitude increase in the photoconductivity of Cs2PbI2Cl2 from its initial value, at the industrially achievable level of 2 GPa, using pressure regulation. Impressively, pressure regulating the 2D perovskite's excitonic features gains it 3D compound characteristics without diminishing its own advantages, making it a more promising material for photovoltaic and photodetector applications. Their study is published as a Cover article in the latest issue of the Journal of the American Chemical Society.
Two-dimensional (2D) halide perovskites have recently emerged for photovoltaic and optoelectronic ...
In a report summary released today Thomas McAndrew, a computational scientist and assistant professor at Lehigh University's College of Health includes probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory over the next few weeks. The goal of the report, says McAndrew, is "to support public health officials, infectious disease modeling groups, and the general public"
Report highlights:
A consensus of 91 forecasters predicts that the B.1.1.7. variant will be found in 42% of all genetic sequences with an S-gene mutation in the first two weeks of March and in 72% in all sequences between ...
Researchers have captured the first detailed images of newborn babies' lungs as they take their first breaths.
The research, led by the Murdoch Children's Research Institute (MCRI) and published the American Journal of Respiratory and Critical Care Medicine, provides a breakthrough in understanding the events around a baby's first breath, why healthy babies cry at birth and provides clues to improving preterm babies' survival chances and long term health outcomes.
About 10 per cent of newborns, and almost all preterm infants, need resuscitation because their lungs do not properly fill with air at birth (a process called lung aeration). Despite ...
New research from UBC finds that higher life satisfaction is associated with better physical, psychological and behavioural health.
The research, published recently in The Milbank Quarterly, found that higher life satisfaction is linked to 21 positive health and well-being outcomes including:
a 26 per cent reduced risk of mortality
a 46 per cent reduced risk of depression
a 25 per cent reduced risk of physical functioning limitations
a 12 per cent reduced risk of chronic pain
a 14 per cent reduced risk of sleep problem onset
an eight per cent higher likelihood of frequent physical activity
better psychological well-being on ...
If you've ever swatted a mosquito away from your face, only to have it return again (and again and again), you know that insects can be remarkably acrobatic and resilient in flight. Those traits help them navigate the aerial world, with all of its wind gusts, obstacles, and general uncertainty. Such traits are also hard to build into flying robots, but MIT Assistant Professor Kevin Yufeng Chen has built a system that approaches insects' agility.
Chen, a member of the Department of Electrical Engineering and Computer Science and the Research Laboratory of Electronics, has developed insect-sized drones with unprecedented dexterity and resilience. The aerial robots ...
Green tea supplements modulate facial development of children with Down syndrome
A new study led by Belgian and Spanish researchers published in Scientific Reports adds evidence about the potential benefits of green tea extracts in Down syndrome. The researchers observed that the intake of green tea extracts can reduce facial dysmorphology in children with Down syndrome when taken during the first three years of life. Additional experimental research in mice confirmed the positive effects at low doses. However, they also found that high doses of the extract can disrupt facial and bone development. More research is needed to fully understand the effects of green tea extracts and therefore they should ...
Imagine a robot.
Perhaps you've just conjured a machine with a rigid, metallic exterior. While robots armored with hard exoskeletons are common, they're not always ideal. Soft-bodied robots, inspired by fish or other squishy creatures, might better adapt to changing environments and work more safely with people.
Roboticists generally have to decide whether to design a hard- or soft-bodied robot for a particular task. But that tradeoff may no longer be necessary.
Working with computer simulations, MIT researchers have developed a concept for a soft-bodied robot that can turn rigid on demand. The approach could enable a new generation of robots that combine the strength and precision of rigid robots with the fluidity and safety of ...
The models used to produce global climate scenarios may overestimate the energy and emission savings from improved energy efficiency, warns new research led by academics at the University of Sussex Business School and the University of Leeds.
In a review of 33 studies, the researchers find that economy wide rebound effects may erode around half of the energy and emission savings from improved energy efficiency.
These rebound effects result from individuals and businesses responding to the benefits of improved energy efficiency - such as cheaper heating, lighting and travel. These responses improve quality-of-life, raise productivity and boost industrial competitiveness, ...
Professor Christiani Jeyakumar Henry, Senior Advisor of Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR) and his team have developed a Glycaemic Index (GI) glossary of non-Western foods. The research paper (attached PDF) was published in Nutrition & Diabetes on 6 Jan 2021: https://doi.org/10.1038/s41387-020-00145-w.
Observational studies have shown that the consumption of low glycaemic index (GI) foods is associated with a lower risk of type 2 diabetes mellitus (T2DM), significantly less insulin resistance and a lower prevalence of the metabolic syndrome. ...
